Sign in

CIK 0001689375

  • Accelerated filer
  • Smaller reporting company
  • Emerging growth company

Entrada Therapeutics, Inc.

Sign in to watch
Ticker
TRDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813983399
Phone
+1 857-305-1825
Business address
ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
Former names
CycloPorters, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,200,939
in 8 filings

Net −$7,200,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-11-02 ROCHE HOLDING LTD 10% owner Conversion +318,140 2,813,525
2021-11-02 ROCHE HOLDING LTD 10% owner Conversion · Series A Preferred Stock −2,495,385 0
2021-11-02 ROCHE HOLDING LTD 10% owner Conversion · Series B Preferred Stock −318,140 0
2021-11-02 Redmile Group, LLC 10% owner Conversion +954,420 954,420
2021-11-02 Redmile Group, LLC 10% owner Purchase +1,000,000 $20.00 $20.0M 1,954,420
2021-11-02 Redmile Group, LLC 10% owner Conversion · Series B Convertible Preferred Stock −954,420 0
2021-10-28 Foley Todd Director Grant or award · Stock Option (Right to Buy) +23,552 23,552
2021-10-28 PARMAR KUSH Director Grant or award · Stock Option (Right to Buy) +23,552 23,552
2021-10-28 WENTWORTH KORY JAMES Chief Financial Officer Grant or award · Stock Option (Right to Buy) +72,012 72,012
2021-10-28 Thistle Mary Director Grant or award · Stock Option (Right to Buy) +11,918 11,918
2021-10-28 Sethuraman Natarajan Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +243,639 243,639
2021-10-28 Nuechterlein Carole Director Grant or award · Stock Option (Right to Buy) +23,552 23,522
2021-10-28 KREHER NERISSA Chief Medical Officer Grant or award · Stock Option (Right to Buy) +72,012 72,012
2021-10-28 KIM PETER S Director Grant or award · Stock Option (Right to Buy) +11,918 11,918
2021-10-28 Dowden Nathan J Chief Operating Officer Grant or award · Stock Option (Right to Buy) +95,148 95,148
2021-10-28 Doshi Dipal President and CEO Grant or award · Stock Option (Right to Buy) +184,821 184,821
2021-10-28 Crowley John F Director Grant or award · Stock Option (Right to Buy) +11,918 11,918

Page 29 of 29 · 577 trades